Literature DB >> 15501395

Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.

Margot Zöller1, Kevin J McElwee, Mario Vitacolonna, Rolf Hoffmann.   

Abstract

Alopecia areata (AA) is a putative, cell-mediated autoimmune disease of anagen stage hair follicles. Inter- and intra-follicular lymphocytic infiltrates are associated with alopecia that may progress from an initially patchy presentation to extensive, even universal, hair loss. We previously noted in a mouse model of AA that regulatory T cells (Treg) are absent from draining lymph nodes and that expression of CD44v7 is transiently upregulated. Both features might explain autoreactive T cell persistence. Here we explored whether similar changes are seen in AA patients' peripheral blood mononuclear cells (PBMC). There was no clear evidence for a reduction in Treg as a possible means to support sustained T cell activation. However, progressive AA patients' PBMC displayed increased resistance towards apoptosis, which was accompanied by a decrease in CD95L+ and an increase in CD44v7+ cells. Notably, an expanded population of CD4+CD25+CD154+ T cells in progressive AA patients' PBMC was apoptosis resistant and expressed CD44v7. Thus, survival of activated T cells in progressive AA patients' PBMC is apparently sustained by downregulation of CD95L and upregulation of CD44v7 which is known to be associated with anti-apoptotic gene expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501395     DOI: 10.1016/j.jaut.2004.08.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  8 in total

Review 1.  The role of lymphocytes in the development and treatment of alopecia areata.

Authors:  Hongwei Guo; Yabin Cheng; Jerry Shapiro; Kevin McElwee
Journal:  Expert Rev Clin Immunol       Date:  2015-09-07       Impact factor: 4.473

Review 2.  Cytokines and other mediators in alopecia areata.

Authors:  Stamatis Gregoriou; Dafni Papafragkaki; George Kontochristopoulos; Eustathios Rallis; Dimitrios Kalogeromitros; Dimitris Rigopoulos
Journal:  Mediators Inflamm       Date:  2010-03-11       Impact factor: 4.711

Review 3.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

4.  Alopecia areata, primary sclerosing cholangitis, and ulcerative colitis: autoimmunity and apoptosis as common links?

Authors:  Panagiotis Katsinelos; Jannis Kountouras; George Paroutoglou; Christos Zavos
Journal:  Dig Dis Sci       Date:  2007-03-20       Impact factor: 3.487

5.  Hypothesis testing: CTLA4 co-stimulatory pathways critical in the pathogenesis of human and mouse alopecia areata.

Authors:  John P Sundberg; Kevin J McElwee; Joseph M Carroll; Lloyd E King
Journal:  J Invest Dermatol       Date:  2011-07-14       Impact factor: 8.551

6.  CD4, CD8 and natural killer cells are depressed in patients with alopecia areata: their association with disease activity.

Authors:  Abdel-Khalek Younes; Refaat Hammad; Mona Othman; Ali Sobhy
Journal:  BMC Immunol       Date:  2022-03-17       Impact factor: 3.615

Review 7.  Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease.

Authors:  Glinda S Cooper; Kathleen M Gilbert; Eric L Greidinger; Judith A James; Jean C Pfau; Leslie Reinlib; Bruce C Richardson; Noel R Rose
Journal:  Environ Health Perspect       Date:  2008-06       Impact factor: 9.031

8.  Altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from patients with alopecia areata.

Authors:  Abdullateef A Alzolibani; Zafar Rasheed; Ghada Bin Saif; Mohammed S Al-Dhubaibi; Ahmad A Al Robaee
Journal:  BBA Clin       Date:  2016-03-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.